Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects
Not Applicable
Completed
- Conditions
- Vertical Alveolar Bone Loss
- Registration Number
- NCT06639555
- Lead Sponsor
- Tsvetalina Gerova-Vatsova
- Brief Summary
Study of the effectiveness of the application of regenerative therapy with autogenous, platelet-rich plasma in vertical defects Investigation of the effectiveness of the application of regenerative therapy with enamel matrix derivatives in vertical bone defects Study of the effectiveness of the application of guided tissue regeneration in vertical bone defects with Barrier membrane and Barrier membrane and autogenous platelet-rich plasma
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
- good oral hygiene
- written informed consent
- age
- no systemic diseases
Exclusion Criteria
- smokers
- horizontal bone loss
- untreated periodontium disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Probing depth in mm 6 months Level of Margo Gingivalis in mm 6 months Clinical attachment level in mm 6 months The distance from the ECJ to the base of the bone defect in mm 6 months The distance from the ECJ to the apex of the bone defect in mm 6 months The width of the bone defect in mm 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Medical University - Varna
🇧🇬Varna, Bulgaria
Medical University - Varna🇧🇬Varna, Bulgaria